Sorry, you need to enable JavaScript to visit this website.

Over the past decade, we’ve taken bold new approaches to translate scientific research into effective medicines for people living with cancer. Now, we’re working tirelessly to develop a new generation of breakthroughs across multiple cancers and tumor types.

  • Bladder cancer is the 6th most common cancer in the U.S. In 2024, an estimated 80,000 new cases of bladder cancer will be diagnosed in the U.S. Men are four times more likely to be diagnosed with bladder cancer than women. Though the rates of both new bladder cancers and deaths from bladder cancer have been dropping in recent years, many people still face cancer progression and advanced bladder cancer is a common cause of cancer-related death.

  • Worldwide, breast cancer is the most common invasive cancer, with more than 2.2 million impacted annually. Metastatic breast cancer (mBC), the most advanced stage of breast cancer in which the cancer has spread beyond the breast to other parts of the body (i.e., organs, bones), remains an incurable disease. As a result of earlier screening, increased awareness, and better treatments, breast cancer deaths have continued to decrease in older women. From 2013 to 2018, the death rate went down by 1% per year. 

    Learn more about Breast Cancer

  • Cervical cancer begins in the cervix, which is found in the lower part of the uterus that connects to the vagina. In 2024, an estimated over 13,000 new cases of cervical cancer will be diagnosed in the U.S. Despite advances in vaccination and preventative screening practices, approximately 15% of patients present with metastatic disease at diagnosis. Among patients with initial diagnosis of early-stage disease, up to 61% will recur. Recurrent or metastatic cervical cancer is a devastating and mostly incurable disease with an urgent need for more treatment options. Patients who experience disease progression on or after first-line systemic therapy have limited effective therapy choices.

  • Worldwide, colorectal cancer is the third most common type of cancer in men, and the second most common in women, with approximately 1.8 million new diagnoses in 2018. In the U.S. alone, an estimated 147,950 people will be diagnosed with cancer of the colon or rectum in 2020, and approximately 53,000 are estimated to die of their disease each year. 

  • Head and neck cancers occur in the larynx, throat, lips, mouth, nose, and salivary glands. About 4% of all cancers in the U.S. are head and neck cancers. These cancers are more than twice as common among men than among women. In 2023, an estimated over 65,000 new cases of head and neck cancer were diagnosed in the U.S. There is a high need for additional effective treatment options for head and neck cancers.

  • Blood cancers strike ruthlessly at any age. Some come fast and take lives within weeks or months. Others develop in the bones and blood over time, requiring intense and aggressive treatment interventions that are traumatic, emotionally overwhelming, and expensive. More than 1 million people worldwide were diagnosed with a blood cancer in 2020, representing almost 6% of all cancer diagnoses globally. In 2020, more than 700,000 people worldwide died from a form of blood cancer. 

     

  • Lung cancer remains the leading cause of cancer-related death among men and women globally, and the global five-year survival rate at 17.8 percent is much lower than leading cancers. Lung cancer is notoriously difficult to treat due to the heterogeneous nature of the disease, variability in testing rates and the onset of drug resistance. These challenges necessitate an individualized approach to treatment, ensuring people with lung cancer receive the right drug at the right time.

    Learn more about Lung Cancer

  • Though melanoma skin cancer is much less common (1%) than some other types of skin cancers, it causes the vast majority of skin cancer deaths. It is considered more dangerous because it’s much more likely to invade nearby tissue and spread to other parts of the body if not caught and treated early when it is most likely to be cured.

    Learn more about Melanoma

  • Prostate cancer is the most common cancer in men in the U.S., aside from non-melanoma skin cancer, and is a leading cause of death from cancer. About 1 in 8 men will be diagnosed with prostate cancer in their lifetimes. Black men are 70% more likely than White men to be diagnosed with prostate cancer. In 2024, an estimated 300,000 new cases of prostate cancer will be diagnosed in the U.S. Though the death rate had been improving, lately this trend has slowed. This change is likely from an increase in later-stage diagnoses that are more difficult to treat.

    Learn more about Prostate Cancer

Cancer is not a singular disease, so our approach to treating it must be every bit as adaptive and nimble as the disease itself. Each day, our scientists get closer to discovering breakthroughs that will save lives.

Cancer is one of the most complex diseases known to mankind. Our scientists explain some of the biggest challenges they’re looking to overcome in cancer research. 

Our Research & Development colleagues are working at sites across the globe to support our product pipeline.

Details from major Research & Development locations are listed below.

Andover, Massachusetts Research Site front entrance
Andover, Massachusetts
A 70-acre site that combines state-of-the-art R&D facilities with flexible, multi-product manufacturing capabilities
Cambridge, Massachusetts Research Site building
Cambridge, Massachusetts
Global headquarters for our Center for Therapeutic Innovation (CTI), which has established locations in New York City, San Diego, and San Francisco
Groton, Connecticut Research Site front Pfizer signage
Groton, Connecticut
Where nearly every one of our products are, in part, developed
La Jolla, California Research Site front entrance
La Jolla, California
Powerfully reinforcing the company's presence in the global biotechnology industry
Pearl River, New York Research Site campus aerial view
Pearl River, New York
The primary location for our company’s global Vaccine Research and Development work
Sandwich, UK Research Site building front
Sandwich, UK
Home of the Pharmaceutical Sciences and Global Regulatory Affairs groups
St. Louis, MO Research Site front entrance
St. Louis, MO
A 300,000 sq. ft. facility producing innovative emergency care products that serve unique needs during severe medical crises

Revolutionary medicines have the power to enrich and extend life across many disease areas. Explore our latest innovations.

Rare Disease
View All Rare Disease

Explore all of our disease and condition-related resources to learn more about your diagnosis and treatment options. 

Gene Therapy
Acromegaly 
Duchenne Muscular Dystrophy 
Gaucher Disease
Growth Hormone Deficiency 
Hemophilia 
Sickle Cell 
Transthyretin Amyloidosis 

Internal Medicine
View All Internal Medicine

We’re developing therapies to treat, slow, or prevent disease progression and improve the quality of life for patients with obesity, type 2 diabetes, and cardiovascular and kidney diseases. 

Inflammation & Immunology
View All Inflammation & Immunology

We look for treatments that provide more than just symptom relief, in order to address the root cause of chronic inflammatory diseases at a molecular level

Vaccines
View All Vaccines

Vaccines are the single most important innovation in the science of health to significantly reduce the threat of diseases that were once widespread and oftentimes fatal. 

Vaccines 
Milestones 
Pipeline & Clinical Trials 

Oncology
View All Oncology

Cancer treatment needs to be transformed across the entire landscape to significantly improve the lives of cancer patients worldwide.

Oncology
Biology into medicine
Advocacy 
Global Impact

Anti Infectives
View All Anti Infectives

Anti-infectives are medicines that work to prevent or treat infections, including antibacterials, antivirals, antifungals, and antiparasitic medications. 

Anti-infectives
Antimicrobial Resistance 
AMR Prevention 
Antimicrobial Surveillance 
Antimicrobial Stewardship 
Our Commitment as a Global Leader 
Environmental Protection 

  • 00Phase 1
  • 00Phase 2
  • 00Phase 3
  • 00Registration
  • 00Total

Meet the people behind our medicines. Our experts make discoveries that give the world cutting-edge treatments for conditions that span the range from the common cold to rare diseases.

Media Name: Olivier_Dirat_300x170px.jpg

Associate Research Fellow and Group Leader, Chemical Development Active Pharmaceutical Ingredients

Media Name: jeff_settleman300x170.jpg

Chief Scientific Officer

Media Name: k_beaverson300x170.jpg

Executive Director, Patient Advocacy Lead

Media Name: Kendra_Bence_300x170px.jpg

Executive Director, Metabolism

Media Name: christian_czech300x170.jpg

Senior Director, Biology and Nice Site Lead

Media Name: jeremy_d_gale300x170.jpg

Vice President and Clinical Portfolio Leader

Media Name: GURTMAN ALEJANDRA 300x170.png

Senior Vice President, Head Vaccine Clinical Research and Development

Aida2_300x170.png

Chief Medical Officer and Head of Worldwide Medical & Safety

Luis Jodar bio pic

Global Vaccines and Antivirals, CMAO

Media Name: Nicholas_Kitchin_300x170px.jpg

VP, Vaccine Clinical Research & Development

Media Name: Jennifer_Lafontaine_300x170px.jpg

Senior Director, Oncology Medicinal Chemistry Synthesis and Analytical Group

Media Name: Carolyn_Leverett_300x170px.jpg

Principal Scientist, Oncology Medicinal Chemistry

bill_sessa_300x170.jpg

Senior Vice President and Chief Scientific Officer, Internal Medicine Research Unit

Media Name: Ravi_Shanker_300x170px.jpg

Senior Research Fellow, Pharmaceutical Sciences

Media Name: Fabien_Vincent_300x170px.jpg

Associate Research Fellow, Hit Discovery and Lead Profiling

Media Name: thomas_a_wynn300x170.jpg

Vice President, Discovery

Media Name: bei_zhang_300x170.jpg

Vice President, Metabolic Research

Show More
Media Name: Olivier_Dirat_300x170px.jpg

Associate Research Fellow and Group Leader, Chemical Development Active Pharmaceutical Ingredients

Media Name: jeff_settleman300x170.jpg

Chief Scientific Officer

Media Name: k_beaverson300x170.jpg

Executive Director, Patient Advocacy Lead

Media Name: Kendra_Bence_300x170px.jpg

Executive Director, Metabolism

Media Name: christian_czech300x170.jpg

Senior Director, Biology and Nice Site Lead

Media Name: jeremy_d_gale300x170.jpg

Vice President and Clinical Portfolio Leader

Media Name: GURTMAN ALEJANDRA 300x170.png

Senior Vice President, Head Vaccine Clinical Research and Development

Aida2_300x170.png

Chief Medical Officer and Head of Worldwide Medical & Safety

Luis Jodar bio pic

Global Vaccines and Antivirals, CMAO

Media Name: Nicholas_Kitchin_300x170px.jpg

VP, Vaccine Clinical Research & Development

Media Name: Jennifer_Lafontaine_300x170px.jpg

Senior Director, Oncology Medicinal Chemistry Synthesis and Analytical Group

Media Name: Carolyn_Leverett_300x170px.jpg

Principal Scientist, Oncology Medicinal Chemistry

bill_sessa_300x170.jpg

Senior Vice President and Chief Scientific Officer, Internal Medicine Research Unit

Media Name: Ravi_Shanker_300x170px.jpg

Senior Research Fellow, Pharmaceutical Sciences

Media Name: Fabien_Vincent_300x170px.jpg

Associate Research Fellow, Hit Discovery and Lead Profiling

Media Name: thomas_a_wynn300x170.jpg

Vice President, Discovery

Media Name: bei_zhang_300x170.jpg

Vice President, Metabolic Research

Media Name: Olivier_Dirat_300x170px.jpg

Associate Research Fellow and Group Leader, Chemical Development Active Pharmaceutical Ingredients

Media Name: jeff_settleman300x170.jpg

Chief Scientific Officer

Media Name: k_beaverson300x170.jpg

Executive Director, Patient Advocacy Lead

Media Name: Kendra_Bence_300x170px.jpg

Executive Director, Metabolism

Media Name: christian_czech300x170.jpg

Senior Director, Biology and Nice Site Lead

Media Name: jeremy_d_gale300x170.jpg

Vice President and Clinical Portfolio Leader

Media Name: GURTMAN ALEJANDRA 300x170.png

Senior Vice President, Head Vaccine Clinical Research and Development

Aida2_300x170.png

Chief Medical Officer and Head of Worldwide Medical & Safety

Luis Jodar bio pic

Global Vaccines and Antivirals, CMAO

Media Name: Nicholas_Kitchin_300x170px.jpg

VP, Vaccine Clinical Research & Development

Media Name: Jennifer_Lafontaine_300x170px.jpg

Senior Director, Oncology Medicinal Chemistry Synthesis and Analytical Group

Media Name: Carolyn_Leverett_300x170px.jpg

Principal Scientist, Oncology Medicinal Chemistry

bill_sessa_300x170.jpg

Senior Vice President and Chief Scientific Officer, Internal Medicine Research Unit

Media Name: Ravi_Shanker_300x170px.jpg

Senior Research Fellow, Pharmaceutical Sciences

Media Name: Fabien_Vincent_300x170px.jpg

Associate Research Fellow, Hit Discovery and Lead Profiling

Media Name: thomas_a_wynn300x170.jpg

Vice President, Discovery

Media Name: bei_zhang_300x170.jpg

Vice President, Metabolic Research

Show More
Media Name: Olivier_Dirat_300x170px.jpg

Associate Research Fellow and Group Leader, Chemical Development Active Pharmaceutical Ingredients

Media Name: jeff_settleman300x170.jpg

Chief Scientific Officer

Media Name: k_beaverson300x170.jpg

Executive Director, Patient Advocacy Lead

Media Name: Kendra_Bence_300x170px.jpg

Executive Director, Metabolism

Media Name: christian_czech300x170.jpg

Senior Director, Biology and Nice Site Lead

Media Name: jeremy_d_gale300x170.jpg

Vice President and Clinical Portfolio Leader

Media Name: GURTMAN ALEJANDRA 300x170.png

Senior Vice President, Head Vaccine Clinical Research and Development

Aida2_300x170.png

Chief Medical Officer and Head of Worldwide Medical & Safety

Luis Jodar bio pic

Global Vaccines and Antivirals, CMAO

Media Name: Nicholas_Kitchin_300x170px.jpg

VP, Vaccine Clinical Research & Development

Media Name: Jennifer_Lafontaine_300x170px.jpg

Senior Director, Oncology Medicinal Chemistry Synthesis and Analytical Group

Media Name: Carolyn_Leverett_300x170px.jpg

Principal Scientist, Oncology Medicinal Chemistry

bill_sessa_300x170.jpg

Senior Vice President and Chief Scientific Officer, Internal Medicine Research Unit

Media Name: Ravi_Shanker_300x170px.jpg

Senior Research Fellow, Pharmaceutical Sciences

Media Name: Fabien_Vincent_300x170px.jpg

Associate Research Fellow, Hit Discovery and Lead Profiling

Media Name: thomas_a_wynn300x170.jpg

Vice President, Discovery

Media Name: bei_zhang_300x170.jpg

Vice President, Metabolic Research

Learn more about the process of joining a clinical trial and find a trial near you.

Go to Pfizer Clinical Trials Site Details